When the IL-17 signaling pathway was blocked using anti-IL17/anti-IL17R neutralizing antibodies in the orthotopic pancreatic cancer mouse model, myeloid cell recruitment decreased, whereas the total number of CD8+ T cells and activated CD8+ T cells increased [51,53]. The gene discussed is IL17A; the disease is pancreatic neoplasm.